BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4852012)

  • 1. Failure to immunize mice by therapeutically killing developing schistosomula (Schistosoma mansoni).
    Pelligrino J; Katz N
    J Parasitol; 1974 Aug; 60(4):727-8. PubMed ID: 4852012
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary clinical trials with oxamniquine, a new antischistosomal agent.
    Katz N; Pellegrino J; Grinbaum E; Chaves A; Zicker F
    Rev Inst Med Trop Sao Paulo; 1973; 15(1):25-9. PubMed ID: 4574207
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with the schistosomicide oxamniquine (UK-4271). I. Activity in rodents and in vitro.
    Foster R; Cheetham BL
    Trans R Soc Trop Med Hyg; 1973; 67(5):674-84. PubMed ID: 4779114
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental chemotherapy of Schistosomiasis mansoni.
    Katz N; Pellegrino J
    Adv Parasitol; 1974; 12():369-90. PubMed ID: 4218060
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of some tetrahydro- and pyrazinoquinolines against early developing forms of Schistosoma mansoni.
    Pellegrino J; Pereira LH; Mello RT; Katz N
    J Parasitol; 1974 Aug; 60(4):723-5. PubMed ID: 4850406
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory trials on oxamniquine (UK-4271), a candidate schistosomicide.
    Fripp PJ
    J Trop Med Hyg; 1973 Dec; 76(12):316-20. PubMed ID: 4203813
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates.
    Foster R; Cheetham BL; King DF
    Trans R Soc Trop Med Hyg; 1973; 67(5):685-93. PubMed ID: 4205106
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
    Jewsbury JM
    Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansonian schistosomiasis.
    da Silva LC; Sette H; Chamone DA; Alquezar AS; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):103-9. PubMed ID: 4845456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental chemotherapy of schistosomiasis mansoni. Schistosomicide activity of precursors of 1,4-naphthylenediamine and naphthoquinone].
    Korolkovas A; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1978; 20(4):219-23. PubMed ID: 725424
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of macrophage activation and resistance by suppressor T lymphocytes in chronic murine Schistosoma mansoni infection.
    Olds GR; Ellner JJ
    J Immunol; 1984 Nov; 133(5):2720-4. PubMed ID: 6237154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach for screening prophylactic agents in schistosomiasis.
    Pereira LH; Pellegrino J; Valadares TE; Mello RT; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1974; 16(3):123-6. PubMed ID: 4425363
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL; Sher A; Lazdins JK; Meltzer MS
    J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of schistosomicides against experimentally established Schistosoma mansoni infections in mice and hamsters.
    Yarinsky A
    J Toxicol Environ Health; 1975 Nov; 1(2):229-42. PubMed ID: 1206769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of schistosomula of Schistosoma mansoni by normal human monocytes.
    Ellner JJ; Mahmoud AA
    J Immunol; 1979 Aug; 123(2):949-51. PubMed ID: 458160
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 4.
    Islip PJ; Closier MD; Neville MC
    J Med Chem; 1974 Feb; 17(2):207-9. PubMed ID: 4203366
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-mediated killing of schistosomula of Schistosoma mansoni: alterations in human Schistosomiasis mansoni and tuberculosis.
    Olds GR; Ellner JJ; el-Kholy A; Mahmoud AA
    J Immunol; 1981 Oct; 127(4):1538-42. PubMed ID: 7276570
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of schistosomula (Schistosoma mansoni) transferred from hamsters to mice immunized against the donor host.
    Coelho PM; Colley DG; Pellegrino J; Pereira LH
    J Parasitol; 1976 Feb; 62(1):159-61. PubMed ID: 1255370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.